This content is machine translated Online training Swiss Oncology in Motion Pancreatic Cancer Module The Pancreatic Cancer module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by Raphaël Delaloye, MD, (Department of Oncology, University Hospital Basel), PD… CME-Test
View Post 2 min This content is machine translated Virtual training series 2022: Dia-Month Club – the diamond among GP training courses on type 2 diabetes Type 2 diabetes – a condition that affects many patients in your family practice. But it is also a disease on which a great deal of research is still being…
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2022) Module 1: Protecting the kidneys with the right therapy Modern diabetes management also protects the kidneys. In the live webinar on June 16, Prof. Roger Lehmann from the University Hospital Zurich used current study data to explain which therapies… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2022) Module 2: Effectively supporting treatment adherence. Modern therapy for type 2 diabetes brings many benefits to patients – but only if it is followed. Doctor Bá Thanh-Trúc Ngô from Centramed Liestal showed in her live webinar… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2022) Module 3: Multifactorial therapy is the key Addressing all cardio-renal risk factors is worthwhile. In her live webinar on October 27, 2022, Prof. Isabella Sudano from the University Hospital Zurich showed how essential it is to effectively…
View Post 12 min This content is machine translated Axial spondyloarthritis and psoriatic arthritis Effective and efficient against pain The anti-IL-17A monoclonal antibody ixekizumab has already been approved since 2016 for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. In 2020, axial spondyloarthritis (axSpA) was added… CME-Test
View Post 11 min This content is machine translated Therapy of rheumatoid arthritis Long-term safety for RA patients under JAK inhibition The treatment of rheumatoid arthritis (RA) has made great progress over the past 20 years. This relates both to the range of drugs available and to developments in terms of… CME-Test
View Post 10 min This content is machine translated New AGLA guidelines Dyslipidemia – when to see a specialist? “The lower the better” – the approach to lower cholesterol levels as much as possible in patients at cardiovascular risk is more relevant than ever, according to the update of… CME-Test
View Post 14 min This content is machine translated Epilepsy Patient-centered pharmacotherapy of epilepsy. The arsenal of available pharmacotherapies for the treatment of epilepsy has expanded dramatically in recent years. More targeted selection and prioritization based on the form of epilepsy, consideration of comorbidities,… CME-Test
View Post 1 min This content is machine translated IBD matters Extraintestinal manifestations and comorbidities Many patients with inflammatory bowel disease (IBD) suffer from disease-associated symptoms outside the gastrointestinal tract. Classic extraintestinal manifestations (EIM) that may occur in association with IBD include rheumatologic, ocular, cutaneous,…
View Post 9 min This content is machine translated "IBD matters" Extraintestinal manifestations of inflammatory bowel diseases (IBD) The leading symptoms of inflammatory bowel disease (IBD) are chronic diarrhea (>4 weeks), abdominal pain, bloody stools, and rapid weight loss. IBD is often relapsing, with active phases alternating with… CME-Test
